Your browser doesn't support javascript.
loading
Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy.
Landsburg, Daniel J; Hughes, Mitchell E; Koike, Alexa; Bond, David; Maddocks, Kami J; Guo, Ling; Winter, Allison M; Hill, Brian T; Ondrejka, Sarah L; Hsi, Eric D; Nasta, Sunita D; Svoboda, Jakub; Schuster, Stephen J; Bogusz, Agata M.
Afiliação
  • Landsburg DJ; Department of Medicine.
  • Hughes ME; Department of Pharmacy, and.
  • Koike A; Department of Pathology, University of Pennsylvania, Philadelphia, PA.
  • Bond D; Department of Internal Medicine and.
  • Maddocks KJ; Department of Internal Medicine and.
  • Guo L; Department of Pathology, The Ohio State University, Columbus, OH; and.
  • Winter AM; Department of Hematology/Oncology and.
  • Hill BT; Department of Hematology/Oncology and.
  • Ondrejka SL; Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH.
  • Hsi ED; Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH.
  • Nasta SD; Department of Medicine.
  • Svoboda J; Department of Medicine.
  • Schuster SJ; Department of Medicine.
  • Bogusz AM; Department of Pathology, University of Pennsylvania, Philadelphia, PA.
Blood Adv ; 3(2): 132-135, 2019 01 22.
Article em En | MEDLINE | ID: mdl-30651281
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Genes myc / Linfoma de Células B / Genes bcl-2 / Inibidores de Proteínas Quinases / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Genes myc / Linfoma de Células B / Genes bcl-2 / Inibidores de Proteínas Quinases / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article